Low dose aspirin and age-related macular degeneration: randomised controlled trial [ 2013 - 2017 ]

Research Grant

Researchers: Prof John Mcneil (Principal investigator) ,  A/Pr Robyn Woods ,  Dr Liubov (Luba) Robman ,  Prof Robyn Guymer

Brief description Age-related macular degeneration (AMD) is a major cause of visual impairment in advanced countries, responsible for nearly half of all legal blindness in Australia. Due to increased life expectancy, the number of people with this progressive late onset disease will double by 2025. Aspirin could prevent or delay the onset of AMD in older persons but its bleeding risk also needs to be considered. This project will determine whether treatment with low dose aspirin reduces incidence or progression of AMD.

Funding Amount $AUD 1,043,189.66

Funding Scheme Project Grants

Notes Standard Project Grant